“…The term âno-reflowâ was coined by Ames in 1968 to describe a period of lack of blood filling the vessels directly after ischemia (Ames et al , 1968) and was first used by Asano and Sano in 1977, to describe early perfusion deficits due to increased ICP in SAH animals (Asano and Sano, 1977). Other factors that contribute to the initial CBF fall in humans include presence of subarachnoid blood (Clower et al , 1994; Ebel et al , 1996; Solomon et al , 1985; Umansky et al , 1983), hypovolemia caused by cerebral salt wasting and excessive urinary output (Solomon et al , 1988), and disturbed autoregulation (Ebel et al , 1996; Jakubowski et al , 1982; Kamiya et al , 1983; Rasmussen et al , 1992). The early CBF reduction after aSAH is accompanied by reduced cerebral metabolic rate of oxygen (Frykholm et al , 2004; Hayashi et al , 2008; Hayashi et al , 2000; Jakobsen et al , 1990; Kawamura et al , 2000) and signs of clinical deterioration (Kobayashi et al , 1979; Miranda et al , 2006).…”